(NPTN) Expected to Post Quarterly Sales of $70.06 Million

Joanna Estrada
April 18, 2018

Approximately 2,234,565 shares changed hands during mid-day trading, an increase of 136% from the average daily volume of 945,141 shares. About 26,064 shares traded. NeoPhotonics Corporation (NYSE:NPTN) has declined 34.12% since April 17, 2017 and is downtrending. It has underperformed by 45.67% the S&P500.

COPYRIGHT VIOLATION NOTICE: This report was published by registrarjournal.com and is the sole property of of registrarjournal.com. Us State Bank De has invested 0% in NeoPhotonics Corporation (NYSE:NPTN). It's down -0.67, from 2.4 in 2017Q3. The investment professionals in our database now own: 7.32 million shares, up from 5.76 million shares in 2017Q3.

A number of other hedge funds have also added to or reduced their stakes in NPTN. NeoPhotonics had a negative net margin of 18.21% and a negative return on equity of 22.53%. Therefore 57% are positive. For the next financial year, analysts forecast that the company will report earnings of $0.01 per share, with EPS estimates ranging from ($0.32) to $0.27.

According to the Recommendation Trends of the stock polled by Finviz, the company has a consensus recommendation of 2.3 out of the scale from 1 to 5 where 1 stands for Buy and 5 means Sell. On Friday, March 2 the firm earned "Buy" rating by Needham. On Friday, March 2 the stock has "Buy" rating by Northland Capital. The stock has "Strong Buy" rating by Raymond James on Wednesday, February 3. The stock of NeoPhotonics Corporation (NYSE:NPTN) has "Buy" rating given on Thursday, May 25 by Rosenblatt. The rating was initiated by Northland Capital on Tuesday, August 18 with "Outperform". FBR Capital maintained AVEO Pharmaceuticals, Inc. The stock of NeoPhotonics Corporation (NYSE:NPTN) earned "Buy" rating by Northland Capital on Friday, November 3.

During Q4 2017 the big money sentiment decreased to 0.84. Shares are now at -19.51% over the past year and year to date performance pointed at -0.91%. It is negative, as 15 investors sold NeoPhotonics Corporation shares while 30 reduced holdings. 12 funds took holdings and 26 increased holdings.

Trust Co Of Vermont accumulated 500 shares. Institutional investors own 78.02% of the company's stock. Balyasny Asset Limited Liability Corporation reported 280,000 shares. Morgan Stanley holds 0% or 144,010 shares in its portfolio.

The stock decreased 0.52% or $0.04 during the last trading session, reaching $6.75.NeoPhotonics Corporation has 1.73M shares volume, 82.82% up from normal.

NeoPhotonics Corporation was covered by a number of analysts recently, 2 rated the stock as Buy, 4 rated Hold, 0 rated sell and 0 gave an Underperform. New York-based Moab Cap Ptnrs Lc has invested 0.05% in NeoPhotonics Corporation (NYSE:NPTN). Moreover, Vanguard Grp has 0% invested in NeoPhotonics Corporation (NYSE:NPTN). Action Hotels had 4 analyst reports since September 8, 2015 according to SRatingsIntel. The Minnesota-based White Pine Capital Llc has invested 0.6% in the stock. Oz Lp has 0% invested in NeoPhotonics Corporation (NYSE:NPTN). It offers high speed products, including transmitter, receiver, and switching products for 100G and optical transmission applications over distances of 2 to 2,000 kilometers; and optical components for coherent systems, including narrow linewidth tunable transmit and local oscillator lasers (NLW-ITLA) that generates ultra-pure wavelength or color for coherent transmission, as well as integrated coherent receivers (ICRs), which decodes the phase and polarization encoded coherent signals.Last it reported negative earnings. The company has market cap of $299.77 million. It now has negative earnings. The firm also engages in developing pluggable coherent modules that combine NLW-ITLA with ICR and a coherent modulator; and offers 100G products for the client side and datacenter applications.

Neophotonics Corp (NYSE:NPTN) has grabbed attention from the analysts, when it saw a value increase of 5.21% or 0.34 points in the last trading session to close at $6.86.

For the current Fiscal Quarter, 1 analysts on average are expecting earnings of $-0.13 per share. The semiconductor company reported ($0.27) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.22) by ($0.05). Inc. holds 0.73% of its portfolio in Luna Innovations Incorporated for 126,548 shares. (NASDAQ:AVEO). Spark Investment Management Ltd Liability Corp owns 268,200 shares. Acuta Cap Prtnrs Ltd Liability Co has invested 0.07% in AVEO Pharmaceuticals, Inc.

Analysts await MidSouth Bancorp, Inc.

Other reports by Click Lancashire

Discuss This Article